Stay updated on Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial
Sign up to get notified when there's something new on the Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial page.

Latest updates to the Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This appears to be a maintenance update and does not modify the study details or user-facing information.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1. This appears to be an internal versioning update with no impact on study details or user-facing content.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor update and does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedResults have been posted for progression-free survival (PFS), overall survival (OS), and toxicity outcomes with a 2-year follow-up. Additional results include the correlation of mid-treatment FDG-PET scans with post-treatment PET-CT and the percentage decrease of MTV2.5 from baseline, along with linked PDFs for the Informed Consent Form and the Study Protocol and statistical analysis plan (SAP).SummaryDifference2%

- Check75 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial page.